A pre-existing protease is a common effector of thymocyte apoptosis mediated by diverse stimuli

FEBS Lett. 1995 Jan 9;357(3):242-6. doi: 10.1016/0014-5793(94)01367-a.

Abstract

Data from a number of model systems support a role for proteolysis in apoptotic cell death. Using immature rat thymocytes, we demonstrate that the inhibitors N-tosyl-L-lysyl chloromethylketone (TLCK) and N-tosyl-L-phenylalanyl chloromethylketone (TPCK) have very different effects on apoptosis. TLCK inhibits apoptosis induced by diverse stimuli at an early stage prior to both DNA fragmentation and cytoplasmic changes. We show that the TLCK-sensitive target is pre-existing and not synthesized in response to apoptotic stimuli. The contrasting effects of TLCK and TPCK support the hypothesis that the TLCK target is a trypsin-like protease which is a common effector of thymocyte apoptosis.

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • DNA / drug effects
  • DNA / metabolism
  • Dexamethasone / pharmacology
  • Endopeptidases / metabolism*
  • Etoposide / pharmacology
  • Flow Cytometry
  • Male
  • Nucleosomes / drug effects
  • Nucleosomes / metabolism
  • Rats
  • Rats, Inbred F344
  • Thymus Gland / cytology
  • Thymus Gland / enzymology*
  • Tosyllysine Chloromethyl Ketone / pharmacology
  • Tosylphenylalanyl Chloromethyl Ketone / pharmacology

Substances

  • Nucleosomes
  • Tosyllysine Chloromethyl Ketone
  • Tosylphenylalanyl Chloromethyl Ketone
  • Etoposide
  • Dexamethasone
  • DNA
  • Endopeptidases